Pharmacopeia's Deals: Renting with an Option to Buy
Combinatorial chemistry remains highly popular in industry, and Pharmacopeia, the premier dealmaker of the still-independent combinatorial chemistry companies, is hoping to translate the industrial popularity to a high market cap as it goes public.
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.